Clinical Trial: Comparing Treatments for Refractory Overactive Bladder: Bladder Denervation Vs Botulinum Toxin Injections

U.S., Jan. 29 -- ClinicalTrials.gov registry received information related to the study (NCT06796855) titled 'Comparing Treatments for Refractory Overactive Bladder: Bladder Denervation Vs Botulinum Toxin Injections' on Jan. 22.

Brief Summary: The goal of this clinical trial is to compare the effectiveness and safety of two treatments for refractory overactive bladder (OAB) in adult women. The main questions it aims to answer are:

Does selective bladder denervation using radiofrequency ablation improve OAB symptoms more effectively than intravesical Onabotulinum toxin A injections? What are the safety profiles of each treatment?

Researchers will compare selective bladder denervation using radiofrequency ablation (RFA) to intravesical Onab...